These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36294819)

  • 21. Myocardial expression profiles of candidate molecules in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia compared to those with dilated cardiomyopathy and healthy controls.
    Akdis D; Medeiros-Domingo A; Gaertner-Rommel A; Kast JI; Enseleit F; Bode P; Klingel K; Kandolf R; Renois F; Andreoletti L; Akdis CA; Milting H; Lüscher TF; Brunckhorst C; Saguner AM; Duru F
    Heart Rhythm; 2016 Mar; 13(3):731-41. PubMed ID: 26569459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced plakoglobin increases the risk of sodium current defects and atrial conduction abnormalities in response to androgenic anabolic steroid abuse.
    Sommerfeld LC; Holmes AP; Yu TY; O'Shea C; Kavanagh DM; Pike JM; Wright T; Syeda F; Aljehani A; Kew T; Cardoso VR; Kabir SN; Hepburn C; Menon PR; Broadway-Stringer S; O'Reilly M; Witten A; Fortmueller L; Lutz S; Kulle A; Gkoutos GV; Pavlovic D; Arlt W; Lavery GG; Steeds R; Gehmlich K; Stoll M; Kirchhof P; Fabritz L
    J Physiol; 2024 Feb; ():. PubMed ID: 38345865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ventricular tachycardia ablation in arrhythmogenic right ventricular cardiomyopathy patients with TMEM43 gene mutations.
    AbdelWahab A; Gardner M; Parkash R; Gray C; Sapp J
    J Cardiovasc Electrophysiol; 2018 Jan; 29(1):90-97. PubMed ID: 28960618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrent missense mutations in TMEM43 (ARVD5) due to founder effects cause arrhythmogenic cardiomyopathies in the UK and Canada.
    Haywood AF; Merner ND; Hodgkinson KA; Houston J; Syrris P; Booth V; Connors S; Pantazis A; Quarta G; Elliott P; McKenna W; Young TL
    Eur Heart J; 2013 Apr; 34(13):1002-11. PubMed ID: 23161701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.
    Calkins H; Corrado D; Marcus F
    Circulation; 2017 Nov; 136(21):2068-2082. PubMed ID: 29158215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular genetics and pathogenesis of arrhythmogenic right ventricular cardiomyopathy: a disease of cardiac stem cells.
    Lombardi R; Marian AJ
    Pediatr Cardiol; 2011 Mar; 32(3):360-5. PubMed ID: 21267716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human pluripotent stem cell line (HDZi001-A) derived from a patient carrying the ARVC-5 associated mutation TMEM43-p.S358L.
    Ratnavadivel S; Szymanski de Toledo M; Rasmussen TB; Šarić T; Gummert J; Zenke M; Milting H
    Stem Cell Res; 2020 Oct; 48():101957. PubMed ID: 32858485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy.
    Ma D; Wei H; Lu J; Ho S; Zhang G; Sun X; Oh Y; Tan SH; Ng ML; Shim W; Wong P; Liew R
    Eur Heart J; 2013 Apr; 34(15):1122-33. PubMed ID: 22798562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracellular calcium current disorder and disease phenotype in
    Chen P; Xiao Y; Wang Y; Zheng Z; Chen L; Yang X; Li J; Wu W; Zhang S
    Theranostics; 2020; 10(24):11215-11229. PubMed ID: 33042279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered Electrical, Biomolecular, and Immunologic Phenotypes in a Novel Patient-Derived Stem Cell Model of Desmoglein-2 Mutant ARVC.
    Hawthorne RN; Blazeski A; Lowenthal J; Kannan S; Teuben R; DiSilvestre D; Morrissette-McAlmon J; Saffitz JE; Boheler KR; James CA; Chelko SP; Tomaselli G; Tung L
    J Clin Med; 2021 Jul; 10(14):. PubMed ID: 34300226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered desmosomal proteins in granulomatous myocarditis and potential pathogenic links to arrhythmogenic right ventricular cardiomyopathy.
    Asimaki A; Tandri H; Duffy ER; Winterfield JR; Mackey-Bojack S; Picken MM; Cooper LT; Wilber DJ; Marcus FI; Basso C; Thiene G; Tsatsopoulou A; Protonotarios N; Stevenson WG; McKenna WJ; Gautam S; Remick DG; Calkins H; Saffitz JE
    Circ Arrhythm Electrophysiol; 2011 Oct; 4(5):743-52. PubMed ID: 21859801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene.
    Merner ND; Hodgkinson KA; Haywood AF; Connors S; French VM; Drenckhahn JD; Kupprion C; Ramadanova K; Thierfelder L; McKenna W; Gallagher B; Morris-Larkin L; Bassett AS; Parfrey PS; Young TL
    Am J Hum Genet; 2008 Apr; 82(4):809-21. PubMed ID: 18313022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arrhythmogenic cardiomyopathy and abnormalities of cell-to-cell coupling.
    Saffitz JE
    Heart Rhythm; 2009 Aug; 6(8 Suppl):S62-5. PubMed ID: 19541548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations in the area composita protein αT-catenin are associated with arrhythmogenic right ventricular cardiomyopathy.
    van Hengel J; Calore M; Bauce B; Dazzo E; Mazzotti E; De Bortoli M; Lorenzon A; Li Mura IE; Beffagna G; Rigato I; Vleeschouwers M; Tyberghein K; Hulpiau P; van Hamme E; Zaglia T; Corrado D; Basso C; Thiene G; Daliento L; Nava A; van Roy F; Rampazzo A
    Eur Heart J; 2013 Jan; 34(3):201-10. PubMed ID: 23136403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Drosophila melanogaster model for TMEM43-related arrhythmogenic right ventricular cardiomyopathy type 5.
    Klinke N; Meyer H; Ratnavadivel S; Reinhardt M; Heinisch JJ; Malmendal A; Milting H; Paululat A
    Cell Mol Life Sci; 2022 Jul; 79(8):444. PubMed ID: 35869176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear plakoglobin is essential for differentiation of cardiac progenitor cells to adipocytes in arrhythmogenic right ventricular cardiomyopathy.
    Lombardi R; da Graca Cabreira-Hansen M; Bell A; Fromm RR; Willerson JT; Marian AJ
    Circ Res; 2011 Dec; 109(12):1342-53. PubMed ID: 22021931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nucleoside Diphosphate Kinase B Contributes to Arrhythmogenesis in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes from a Patient with Arrhythmogenic Right Ventricular Cardiomyopathy.
    Buljubasic F; El-Battrawy I; Lan H; Lomada SK; Chatterjee A; Zhao Z; Li X; Zhong R; Xu Q; Huang M; Liao Z; Lang S; Cyganek L; Zhou X; Wieland T; Borggrefe M; Akin I
    J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32050722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant accumulation of TMEM43 accompanied by perturbed transmural gene expression in arrhythmogenic cardiomyopathy.
    Shinomiya H; Kato H; Kuramoto Y; Watanabe N; Tsuruda T; Arimura T; Miyashita Y; Miyasaka Y; Mashimo T; Takuwa A; Motooka D; Okuzaki D; Matsuoka K; Tsukamoto O; Hakui H; Yamada N; Lee JK; Kioka H; Kitakaze M; Takashima S; Sakata Y; Asano Y
    FASEB J; 2021 Nov; 35(11):e21994. PubMed ID: 34674311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arrhythmogenic right ventricular cardiomyopathy, clinical manifestations, and diagnosis.
    Haugaa KH; Haland TF; Leren IS; Saberniak J; Edvardsen T
    Europace; 2016 Jul; 18(7):965-72. PubMed ID: 26498164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systems genetics analysis defines importance of TMEM43/
    Gu Q; Xu F; Orgil BO; Khuchua Z; Munkhsaikhan U; Johnson JN; Alberson NR; Pierre JF; Black DD; Dong D; Brennan JA; Cathey BM; Efimov IR; Towbin JA; Purevjav E; Lu L
    Physiol Genomics; 2022 Jan; 54(1):22-35. PubMed ID: 34766515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.